Sialyl-glycopeptides containing an 0-glycosidically linked tetrasaccharide chain were obtained from the urine of a patient suffering from mucolipidosis I. Isolation of these compounds was achieved by gel filtration, ion-exchange chromatography and preparative paper chromatography. Their structures were determined by a combination of carbohydrate and amino acid analysis, dansylation, periodate oxidation, methylation studies, enzymatic hydrolysis and 'H-NMR spectroscopy, to be as follows:wherein R = peptide linked through -Thr-, -Ser-, -Ser-Thr-or -Thr-Ser-.The finding of these glycopeptides in urine shows that mucolipidosis I is characterized by a general "glycoproteinspecific" sialidase deficiency. The possibility of the existence of a human endo-a-N-acetylgalactosaminidase is discussed.Mucolipidosis I (MLP-I, one of the forms of sialidosis) is an inherited metabolic disease characterized clinically by the presence of a cherry-red spot on the fundus, by elective overload of the Kupffer cells and by a variety of neurological syndroms. Chemical studies of this disease showed accumulation of abnormal amounts of sialic-acid-containing compounds in fibroblasts and leukocytes of the patients, due to a deficiency of sialidase activity in these cells. By consequence, an enhanced excretion of sialic-acid-containing oligosaccharides was observed in the urine of MLP-I patients; these oligosaccharides originate from the impaired catabolism of N-glycosidic glycoprotein carbohydrate chains [I -41.However, the sialidase deficiency in MLP-I does not only affect the catabolism of the N-glycosidic type of glycoprotein oligosaccharides but, as previously reported by us [5] and others [6], also the excretion of the 0-glycosidic type of glycoprotein carbohydrates is found increased about tenfold in MLP-I urine, as compared to normal. Structural studies on the excreted sialic-acid-containing compounds of the 0-glycosidic type have been scarce until now; however, the occurrence of a Abbreviations. MLP-I, mucolipidosis I; 'H-NMR, proton nuclear magnetic resonance; NeuAc, N-acetylneuraminic acid ; Gal, galactose; CalNAc, N-acetylgalactosamine; 2,4,6-Me3-Gal-ol, 2,4,6-tri-Ornethyl-l,3,5-tri-O-acetyl-galactitol; 2,3,4,6-Me4-Gal-ol, 2,3,4,6-tetra-O-methyl-1,5-di-O-acetyl-galactitol; 4-Me-GalNAc(Me)-ol, 2-deoxy -2 -N -methylace tamido -4-mono -0 -methyl -1,3,5,6 -te tra-0 -acetyl-galactitol; 4,6-Me2-GalNAc(Me)-01, 2-deoxy-2-N-methylacetamido-4,6-di-O-methyl-l,3,5-tri-O-acetyl-galactitol.Enzymes. a-Neuraminidase (EC 3.2.1.18); P-D-galactosidase (EC 3.2.1.23).glyco-aminoacid constituted of NeuAc, GalNAc and Ser has been reported [7].The present work describes the structure determination of some sialyl-glycopeptides of the 0-glycosidic type isolated from the urine of a patient suffering from MLP-I. The results provide further insight into the biochemical consequences of the enzyme deficiency. A preliminary account of the outcome of the structural studies has been presented [S].
MATERIALS AND METHODS
MaterialsUrine of a patient (P.P.) with MLP-...